You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 6,762,180


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,762,180
Title: Substituted indolines which inhibit receptor tyrosine kinases
Abstract:Indolinones of the formula ##STR1## having an inhibitory effect on receptor tyrosine kinases and cyclin/CDK complexes, as well as on the proliferation of endothelial cells and various tumor cells. Exemplary are: (a) 3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycar bonyl-2-indolinone, (b) 3-Z-[(1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-methylene]-6-carbamoy l-2-indolinone, and (c) 3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-methylene]-6-metboxyca rbonyl-2-indolinone.
Inventor(s): Roth; Gerald Juergen (Biberach, DE), Heckel; Armin (Biberach, DE), Walter; Rainer (Biberach, DE), Van Meel; Jacobus (Moedling, AT), Redemann; Norbert (Biberach, DE), Tontsch-Grunt; Ulrike (Baden, AT), Spevak; Walter (Oberrohrbach, AT), Hilberg; Frank (Vienna, AT)
Assignee: Boehringer Ingelheim Pharma KG (Ingelheim, DE)
Application Number:09/678,682
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,762,180
Patent Claims: 1. A compound of the formula I ##STR10##

wherein: X denotes an oxygen atom, R.sub.1 denotes a hydrogen atom or a C.sub.1-4 -alkoxycarbonyl or C.sub.2-4 -alkanoyl group, R.sub.2 denotes a carboxy group, a straight-chain or branched C.sub.1-6 -alkoxy-carbonyl group, a C.sub.4-7 -cycloalkoxy-carbonyl or an aryloxycarbonyl group, a straight-chain or branched C.sub.1-6 -alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a phenyl, heteroaryl, carboxy, C.sub.1-3 -alkoxy-carbonyl, aminocarbonyl, C.sub.1-3 -alkylamino carbonyl or di-(C.sub.1-3 -alkyl)-aminocarbonyl group, a straight-chain or branched C.sub.2-6 -alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a chlorine atom or a hydroxy, C.sub.1-3 -alkoxy, amino, C.sub.1-3 -alkylamino or di-(C.sub.1-3 -alkyl)-amino group, an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally substituted in the 2 position of the ethyl group by a hydroxy or C.sub.1-3 -alkoxy group, R.sub.3 denotes a hydrogen atom, a C.sub.1-6 -alkyl, C.sub.3-7 -cycloalkyl, trifluoromethyl or heteroaryl group, a phenyl or naphthyl group, a phenyl or naphthyl group mono- or disubstituted by a fluorine, chlorine, bromine or iodine atom, by a trifluoromethyl, C.sub.1-3 -alkyl or C.sub.1-3 -alkoxy group, whilst in the event of disubstitution the substituents may be identical or different and wherein the abovementioned unsubstituted as well as the mono- and disubstituted phenyl and naphthyl groups may additionally be substituted by a hydroxy, hydroxy-C.sub.1-3 -alkyl or C.sub.1-3 -alkoxy-C.sub.1-3 -alkyl group, by a cyano, carboxy, carboxy-C.sub.1-3 -alkyl, C.sub.1-3 -alkoxycarbonyl, aminocarbonyl, C.sub.1-3 -alkylamino-carbonyl or di-(C.sub.1-3 -alkyl)-aminocarbonyl group, by a nitro group, by an amino, C.sub.1-3 -alkylamino, di-(C.sub.1-3 -alkyl)-amino or amino--C.sub.1-3 -alkyl group, by a C.sub.1-3 -alkylcarbonylamino, N--(C.sub.1-3 -alkyl)--C.sub.1-3 -alkylcarbonylamino, C.sub.1-3 -alkylcarbonylamino-C.sub.1-3 -alkyl, N--(C.sub.1-3 -alkyl)--C.sub.1-3 -alkylcarbonylamino-C.sub.1-3 -alkyl, C.sub.1-3 -alkyl-sulphonylamino, C.sub.1-3 -alkylsulphonylamino-C.sub.1-3 -alkyl, N--(C.sub.1-3 -alkyl)--C.sub.1-3 -alkylsulphonylamino-C.sub.1-3 -alkyl or aryl-C.sub.1-3 -alkylsulphonylamino group, by a cycloalkylamino, cycloalkyleneimino, cycloalkyleneiminocarbonyl, cycloalkyleneimino-C.sub.1-3 -alkyl, cycloalkyleneiminocarbonyl-C.sub.1-3 -alkyl or cycloalkyleneiminosulphonyl-C.sub.1-3 -alkyl group having 4 to 7 ring members in each case, whilst in each case the methylene group in position 4 of a 6- or 7-membered cycloalkyleneimino group may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, --NH or --N(C.sub.1-3 -alkyl) group, or by a heteroaryl or heteroaryl-C.sub.1-3 -alkyl group, R.sub.4 denotes a C.sub.3-7 -cycloalkyl group, whilst the methylene group in the 4 position of a 6- or 7-membered cycloalkyl group may be substituted by an amino, C.sub.1-3 -alkylamino or di-(C.sub.1-3 -alkyl)-amino group or replaced by an --NH or --N(C.sub.1-3 -alkyl) group, or a phenyl group substituted by the group R.sub.6, which may additionally be mono- or disubstituted by fluorine, chlorine, bromine or iodine atoms, by C.sub.1-5 -alkyl, trifluoromethyl, hydroxy, C.sub.1-3 -alkoxy, carboxy, C.sub.1-3 -alkoxycarbonyl, amino, acetylamino, C.sub.1-3 -alkyl-sulphonylamino, aminocarbonyl, C.sub.1-3 -alkyl-aminocarbonyl, di-(C.sub.1-3 -alkyl)-aminocarbonyl, aminosulphonyl, C.sub.1-3 -alkyl-aminosulphonyl, di-(C.sub.1-3 -alkyl)-aminosulphonyl, nitro or cyano groups, wherein the substituents may be identical or different and wherein R.sub.6 denotes a hydrogen, fluorine, chlorine, bromine or iodine atom, a cyano, nitro, amino, C.sub.1-5 -alkyl, C.sub.3-7 -cycloalkyl, trifluoromethyl, phenyl, tetrazolyl or heteroaryl group, the group of formula ##STR11## wherein the hydrogen atoms bound to a nitrogen atom may in each case be replaced independently of one another by a C.sub.1-3 -alkyl group, a C.sub.1-3 -alkoxy group, a C.sub.1-3 -alkoxy-C.sub.1-3 -alkoxy, phenyl-C.sub.1-3 -alkoxy, amino-C.sub.2-3 -alkoxy, C.sub.1-3 -alkylamino-C.sub.2-3 -alkoxy, di-(C.sub.1-3 -alkyl-amino-C.sub.2-3 -alkoxy, phenyl-C.sub.1-3 -alkylamino-C.sub.2-3 -alkoxy, N--(C.sub.1-3 -alkyl)-phenyl-C.sub.1-3 -alkylamino-C.sub.2-3 -alkoxy, C.sub.5-7 -cycloalkyleneimino-C.sub.2-3 -alkoxy or C.sub.1-3 -alkylmercapto group, a carboxy, C.sub.1-4 -alkoxycarbonyl, aminocarbonyl, C.sub.1-3 -alkylamino-carbonyl, N--(C.sub.1-5 -alkyl)--C.sub.1-3 -alkylaminocarbonyl, phenyl-C.sub.1-3 -alkylamino-carbonyl, N--(C.sub.1-3 -alkyl)-phenyl-C.sub.1-3 -alkylamino-carbonyl, piperazinocarbonyl or N--(C.sub.1-3 -alkyl)-piperazinocarbonyl group, a C.sub.1-3 -alkylaminocarbonyl or N--(C.sub.1-5 -alkyl)--C.sub.1-3 -alkylaminocarbonyl group wherein an alkyl moiety is substituted by a carboxy or C.sub.1-3 -alkoxycarbonyl group or in the 2 or 3 position by a di-(C.sub.1-3 -alkyl)-amino, piperazino, N--(C.sub.1-3 -alkyl)-piperazino or a 4- to 7-membered cycloalkyleneimino group, a C.sub.3-7 -cycloalkyl-carbonyl group, wherein the methylene group in the 4 position of the 6- or 7-membered cycloalkyl moiety may be substituted by an amino, C.sub.1-3 -alkylamino or di-(C.sub.1-3 -alkyl)-amino group or replaced by an --NH or --N(C.sub.1-3 -alkyl) group, a 4- to 7-membered cycloalkyleneimino group wherein a methylene group linked to the imino group may be replaced by a carbonyl or sulphonyl group or the cycloalkylene moiety may be fused to a phenyl ring or one or two hydrogen atoms may each be replaced by a C.sub.1-3 -alkyl group and/or in each case the methylene group in the 4 position of a 6- or 7-membered cycloalkyleneimino group may be substituted by a carboxy, C.sub.1-3 -alkoxycarbonyl, aminocarbonyl, C.sub.1-3 -alkylaminocarbonyl, di-(C.sub.1-3 -alkyl)-aminocarbonyl, phenyl-C.sub.1-3 -alkylamino or N--(C.sub.1-3 -alkyl)-phenyl-C.sub.1-3 -alkylamino group or may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, --NH, --N(C.sub.1-3 -alkyl), --N(phenyl), --N(C.sub.1-3 -alkyl-carbonyl) or --N(benzoyl) group, a C.sub.1-4 -alkyl group substituted by the group R.sub.7, wherein R.sub.7 denotes a C.sub.3-7 -cycloalkyl group, whilst the methylene group in the 4 position of a 6- or 7-membered cycloalkyl group may be substituted by an amino, C.sub.1-3 -alkylamino or di-(C.sub.1-3 -alkyl)-amino group or replaced by an --NH or --N(C.sub.1-3 -alkyl) group or in a 5- to 7-membered cycloalkyl group a --(CH.sub.2).sub.2 group may be replaced by a --CO--NH group, a --(CH.sub.2).sub.3 group may be replaced by a --NH--CO--NH or --CO--NH--CO group or a --(CH.sub.2).sub.4 group may be replaced by a --NH--CO--NH--CO group, whilst in each case a hydrogen atom bound to a nitrogen atom may be replaced by a C1-3-alkyl group, an aryl or heteroaryl group, a hydroxy or C.sub.1-3 -alkoxy group, an amino, C.sub.1-7 -alkylamino, di-(C.sub.1-7 -alkyl)-amino, phenylamino, N-phenyl-C.sub.1-3 -alkyl-amino, phenyl-C.sub.1-3 -alkylamino, N--(C.sub.1-3 -alkyl)-phenyl-C.sub.1-3 -alkylamino or di-(phenyl-C.sub.1-3 -alkyl)-amino group, an .omega.-hydroxy-C.sub.2-3 -alkyl-amino, N--(C.sub.1-3 -alkyl)-.omega.-hydroxy-C.sub.2-3 -alkyl-amino, di-(.omega.-hydroxy-C.sub.2-3 -alkyl)-amino, di-(.omega.-(C.sub.1-3 -alkoxy)--C.sub.2-3 -alkyl)-amino or N-(dioxolan-2-yl)--C.sub.1-3 -alkyl-amino group, a C.sub.1-3 -alkylcarbonylamino-C.sub.2-3 -alkyl-amino or C.sub.1-3 -alkylcarbonylamino-C.sub.2-3 -alkyl-N--(C.sub.1-3 -alkyl)-amino group, a C.sub.1-3 -alkylsulphonylamino, N--(C.sub.1-3 -alkyl)--C.sub.1-3 -alkylsulphonylamino, C.sub.1-3 -alkylsulphonylamino-C.sub.2-3 -alkyl-amino or C.sub.1-3 -alkylsulphonylamino-C.sub.2-3 -alkyl-N--(C.sub.1-3 -alkyl)-amino group, a hydroxycarbonyl-C.sub.1-3 -alkylamino or N--(C.sub.1-3 -alkyl)-hydroxycarbonyl-C.sub.1-3 -alkyl-amino group, a guanidino group wherein one or two hydrogen atoms may each be replaced by a C.sub.1-3 -alkyl group, a group of formula

or a tautomer or salt thereof.

2. A compound of the formula I according to claim 1, wherein: R.sub.1 and R.sub.3 are as defined in claim 1, X denotes an oxygen atom, R.sub.2 denotes a carboxy group, a straight-chain or branched C.sub.1-6 -alkoxy-carbonyl group, a C.sub.5-7 -cycloalkoxycarbonyl or a phenoxycarbonyl group, a straight-chain or branched C.sub.1-3 -alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a phenyl, heteroaryl, carboxy, C.sub.1-3 -alkoxycarbonyl, aminocarbonyl, C.sub.1-3 -alkylaminocarbonyl or di-(C.sub.1-3 -alkyl)-aminocarbonyl group, a straight-chain or branched C.sub.2-3 -alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a chlorine atom, by a hydroxy, C.sub.1-3 -alkoxy, amino, C.sub.1-3 -alkylamino or di-(C.sub.1-3 -alkyl)-amino group, an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally substituted in the 2 position of the ethyl group by a hydroxy or C.sub.1-3 -alkoxy group, R.sub.4 denotes a C.sub.3-7 -cycloalkyl group, whilst the methylene group in the 4 position of a 6 or 7-membered cycloalkyl group may be substituted by an amino, C.sub.1-3 -alkylamino or di-(C.sub.1-3 -alkyl)-amino group or replaced by an --NH or --N(C.sub.1-3 -alkyl) group, or a phenyl group substituted by the group R.sub.6, which may additionally be mono- or disubstituted by fluorine, chlorine or bromine atoms, by C.sub.1-3 -alkyl, trifluoromethyl, hydroxy, C.sub.1-3 -alkoxy, carboxy, C.sub.1-3 -alkoxycarbonyl, amino, acetylamino, aminocarbonyl, C.sub.1-3 -alkyl-aminocarbonyl, di-(C.sub.1-3 -alkyl)-aminocarbonyl, nitro or cyano groups, wherein the substituents may be identical or different and wherein R.sub.6 denotes a hydrogen, fluorine, chlorine, bromine or iodine atom, a cyano, nitro, amino, C.sub.1-5 -alkyl, C.sub.3-7 -cycloalkyl, trifluoromethyl, phenyl, tetrazolyl or heteroaryl group, the group of formula ##STR12## wherein a hydrogen atom bound to the nitrogen atom may be replaced by a C.sub.1-3 -alkyl group, a C.sub.1-3 -alkoxy group, an amino-C.sub.2-3 -alkoxy, C.sub.1-3 -alkylamino-C.sub.2-3 -alkoxy, di-(C.sub.1-3 -alkyl)-amino-C.sub.2-3 -alkoxy, phenyl-C.sub.1-3 -alkylamino-C.sub.2-3 -alkoxy, N--(C.sub.1-3 -alkyl)-phenyl-C.sub.1-3 -alkylamino-C.sub.2-3 -alkoxy, pyrrolidino-C.sub.2-3 -alkoxy, piperidino-C.sub.2-3 -alkoxy or C.sub.1-3 -alkylmercapto group, a carboxy, C.sub.1-4 -alkoxycarbonyl, aminocarbonyl, C.sub.1-3 -alkylamino-carbonyl, phenyl-C.sub.1-3 -alkylamino-carbonyl or N--(C.sub.1-3 -alkyl)-phenyl-C.sub.1-3 -alkylamino-carbonyl group, a C.sub.3-7 -cycloalkyl-carbonyl group, wherein the methylene group in the 4 position of the 6- or 7-membered cycloalkyl moiety may be replaced by an --NH or --N(C.sub.1-3 -alkyl) group, a 4- to 7-membered cycloalkyleneimino group, wherein a methylene group linked to the imino group may be replaced by a carbonyl or sulphonyl group or one or two hydrogen atoms may each be replaced by a C.sub.1-3 -alkyl group and/or in each case the methylene group in the 4 position of a 6- or 7-membered cycloalkyleneimino group may be substituted by a carboxy, C.sub.1-3 -alkoxycarbonyl, aminocarbonyl, C.sub.1-3 -alkylaminocarbonyl, di-(C.sub.1-3 -alkyl)-aminocarbonyl, phenyl-C.sub.1-3 -alkylamino or N--(C.sub.1-3 -alkyl)-phenyl-C.sub.1-3 -alkylamino group or may be replaced by an oxygen or sulphur atom, by a sulphinyl, sulphonyl, --NH or --N(C.sub.1-3 -alkyl) group, a C.sub.1-4 -alkyl group terminally substituted by the group R.sub.7, wherein R.sub.7 denotes a C.sub.5-7 -cycloalkyl group, whilst the methylene group in the 4 position of a 6- or 7-membered cycloalkyl group may be replaced by an --NH or --N(C.sub.1-3 -alkyl) group or in a 5- to 7-membered cycloalkyl group a --(CH.sub.2).sub.2 group may be replaced by a --CO--NH group, a --(CH.sub.2).sub.3 group may be replaced by a --NH--CO--NH-- or a --(CH.sub.2).sub.4 group may be replaced by a --NH--CO--NH--CO group, whilst in each case a hydrogen atom bound to a nitrogen atom may be replaced by a C.sub.1-3 -alkyl group, a phenyl or heteroaryl group, a hydroxy or C.sub.1-3 -alkoxy group, an amino, C.sub.1-6 -alkylamino, di-(C.sub.1-6 -alkyl)-amino, phenylamino, N-phenyl-C.sub.1-3 -alkyl-amino, phenyl-C.sub.1-3 -alkylamino, N--(C.sub.1-3 -alkyl)-phenyl-C.sub.1-3 -alkylamino or di-(phenyl-C.sub.1-3 -alkyl)-amino group, a .omega.-hydroxy-C.sub.2-3 -alkyl-amino, N--(C.sub.1-3 -alkyl).omega.-hydroxy-C.sub.2-3 -alkyl-amino, di-(.omega.-hydroxy-C.sub.2-3 -alkyl)-amino, di-(.omega.-(C.sub.1-3 -alkoxy)--C.sub.2-3 -alkyl)-amino or N--(dioxolan-2-yl)--C.sub.1-3 -alkyl-amino group, a C.sub.1-3 -alkylcarbonylamino-C.sub.2-3 -alkyl-amino or C.sub.1-3 -alkylcarbonylamino-C.sub.2-3 -alkyl-N--(C.sub.1-3 -alkyl)-amino group, a C.sub.1-3 -alkylsulphonylamino, N--(C.sub.1-3 -alkyl)--C.sub.1-3 -alkylsulphonylamino, C.sub.1-3 -alkylsulphonylamino-C.sub.2-3 -alkyl-amino or C.sub.1-3 -alkylsulphonylamino-C.sub.2-3 -alkyl-N--(C.sub.1-3 -alkyl)-amino group, a hydroxycarbonyl-C.sub.1-3 -alkylamino or N--(C.sub.1-3 -alkyl)-hydroxycarbonyl-C.sub.1-3 -alkyl-amino group a guanidino group wherein a hydrogen atom may be replaced by a C.sub.1-3 -alkyl group, a group of formula

--N(R.sub.8)--CO--(CH.sub.2).sub.n -R.sub.9 (II), wherein R.sub.8 denotes a hydrogen atom or a C.sub.1-3 -alkyl group, n denotes one of the numbers 0, 1, 2 or 3 and R.sub.9 denotes an amino, C.sub.1-3 -alkylamino, di-(C.sub.1-3 -alkyl)-amino, phenylamino, benzylamino or C.sub.1-4 -alkoxy group, a 5- to 7-membered cycloalkyleneimino group, wherein the methylene group in position 4 of the piperidino group may be replaced by an oxygen or sulphur atom, by an --NH, --N(C.sub.1-3 -alkyl), --N(phenyl), --N(C.sub.1-3 -alkyl-carbonyl) or --N(benzoyl) group, or, if n denotes one of the numbers 1, 2 or 3, it may also denote a hydrogen atom, a group of formula

or a tautomer or salt thereof.

3. A compound of the formula I according to claim 1, wherein: X denotes an oxygen atom, R.sub.1 denotes a hydrogen atom, R.sub.2 denotes a carboxy group, a straight-chain or branched C.sub.1-4 -alkoxycarbonyl group or a phenoxycarbonyl group, a straight-chain or branched C.sub.1-3 -alkoxy-carbonyl group, which is terminally substituted in the alkyl moiety by a phenyl, carboxy, C.sub.1-3 -alkoxycarbonyl, aminocarbonyl, C.sub.1-3 -alkylaminocarbonyl or di-(C.sub.1-3 -alkyl)-aminocarbonyl group, a straight-chain or branched C.sub.2-3 -alkoxy-carbonyl group which is terminally substituted in the alkyl moiety by a hydroxy, C.sub.1-3 -alkoxy, amino, C.sub.1-3 -alkylamino or di-(C.sub.1-3 -alkyl)-amino group, an aminocarbonyl or methylaminocarbonyl group, an ethylaminocarbonyl group optionally substituted in the 2 position of the ethyl group by a hydroxy or C.sub.1-3 -alkoxy group or, if R.sub.4 does not denote an aminosulphonyl-phenyl or N--(C.sub.1-5 -alkyl)--C.sub.1-3 -alkylaminocarbonyl-phenyl group, it may also denote a di-(C.sub.1-2 -alkyl)-aminocarbonyl group, R.sub.3 denotes a C.sub.1-4 -alkyl group or a phenyl group which may be substituted by a fluorine, chlorine or bromine atom, by a trifluoromethyl, C.sub.1-3 -alkyl, hydroxy or C.sub.1-3 -alkoxy group, R.sub.4 denotes a C.sub.5-6 -cycloalkyl group, wherein the methylene group in position 4 of the cyclohexyl group may be substituted by an amino, C.sub.1-3 -alkylamino or di-(C.sub.1-3 -alkyl)-amino group or replaced by an --NH or --N(C.sub.1-3 -alkyl) group, a phenyl group, a phenyl group disubstituted by C.sub.1-3 -alkyl, C.sub.1-3 -alkoxy or nitro groups, wherein the substituents may be identical or different, or a phenyl group substituted by the group R.sub.6, which may additionally be substituted by a fluorine, chlorine or bromine atom or by an amino or nitro group, wherein R.sub.6 denotes a fluorine, chlorine or bromine atom, a C.sub.1-3 -alkyl, C.sub.1-3 -alkoxy, nitro, amino or C.sub.5-6 -cycloalkyl group, a pyrrolyl, pyrazolyl, imidazolyl, triazolyl or tetrazolyl group bound via a carbon atom, wherein the abovementioned heteroaromatic groups in the carbon skeleton may be substituted by a C.sub.1-3 -alkyl group or a hydrogen atom bound to a nitrogen atom may be replaced by a C.sub.1-3 -alkyl or phenyl-C.sub.1-3 -alkyl group, the group of formula ##STR13## a carboxy, C.sub.1-4 -alkoxycarbonyl, phenyl-C.sub.1-3 -alkylamino-carbonyl or C.sub.5-7 -cycloalkyl-carbonyl group, a 5 or 6-membered cycloalkyleneimino group, wherein the methylene group in position 4 of the piperidino group may be replaced by an oxygen or sulphur atom, by an --NH or --N(C.sub.1-3 -alkyl) group, an unbranched C.sub.1-3 -alkyl group terminally substituted by the group R.sub.7, wherein R.sub.7 denotes a C.sub.5-7 -cycloalkyl group, wherein in a 5 or 6-membered cycloalkyl group a --(CH.sub.2).sub.2 group may be replaced by a --CO--NH group, a --CH.sub.2).sub.3 group may be replaced by an --(NH--CO--NH-- or a --(CH.sub.2).sub.4 group may be replaced by an --NH--CO--NH--CO group, whilst in each case a hydrogen atom bound to a nitrogen atom may be replaced by a C.sub.1-3 -alkyl group, a phenyl or pyridinyl group or a pyrrolyl, pyrazolyl, imidazolyl or triazolyl group bound via a carbon or nitrogen atom, wherein the abovementioned heteroaromatic groups in the carbon skeleton may be substituted by a C.sub.1-3 -alkyl group or a hydrogen atom bound to a nitrogen atom may be replaced by a C.sub.1-3 -alkyl group, a hydroxy or C.sub.1-3 -alkoxy group, an amino, C.sub.1-6 -alkylamino, di-(C.sub.1-6 -alkyl)-amino, phenylamino, N-phenyl-C.sub.1-3 -alkylamino, phenyl-C.sub.1-3 -alkylamino or N--(C.sub.1-3 -alkyl)-phenyl-C.sub.1-3 -alkylamino group, a .omega.-hydroxy-C.sub.2-3 -alkyl-amino, N--(C.sub.1-3 -alkyl)-.omega.-hydroxy-C.sub.2-3 -alkylamino, di-(.omega.-hydroxy-C.sub.2-3 -alkyl)-amino or di-(.omega.-(C.sub.1-3 -alkoxy)--C.sub.2-3 -alkyl)-amino group, a C.sub.1- 3-alkylcarbonylamino-C.sub.2-3 -alkyl-amino or C.sub.1-3 -alkylcarbonylamino-C.sub.2-3 -alkyl-N--(C.sub.1-3 -alkyl)-amino group, a C.sub.1-3 -alkylsulphonylamino, N--(C.sub.1-3 -alkyl)--C.sub.1-3 -alkylsulphonylamino, C.sub.1-3 -alkylsulphonylamino-C.sub.2-3 -alkylamino or C.sub.1-3 -alkylsulphonylamino-C.sub.2-3 -alkyl-N--(C.sub.1-3 -alkyl)-amino group, a hydroxycarbonyl-C.sub.1-3 -alkylamino or N--(C.sub.1-3 -alkyl)-hydroxycarbonyl-C.sub.1-3 -alkyl-amino group, a guanidino group wherein a hydrogen atom may be replaced by a C.sub.1-3 -alkyl group, a group of formula

or a tautomer or salt thereof.

4. A compound of the formula I according to claim 1, wherein: X denotes an oxygen atom, R.sub.1 and R.sub.5 each denote a hydrogen atom, R.sub.2 denotes a methoxycarbonyl, ethoxycarbonyl or aminocarbonyl group, R.sub.3 denotes a phenyl group and R.sub.4 denotes a phenyl group monosubstituted by the group R.sub.6, wherein R.sub.6 denotes an N-methyl-imidazol-2-yl group, an unbranched C.sub.1-3 -alkyl group which is terminally substituted by a C.sub.1-4 -alkylamino, di-(C.sub.1-4 -alkyl)-amino, piperidino or 2,6-dimethyl-piperidino group, a group of formula

or a tautomer or salt thereof.

5. A compound selected from the group consisting of: (a) 3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-methylene]-6-ethoxycar bonyl-2-indolinone, (b) 3-Z-[(1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-methylene]-6-carbamoy l-2-indolinone, (c) 3-Z-[1-(4-(piperidin-1-yl-methyl)-anilino)-1-phenyl-methylene]-6-methoxyca rbonyl-2-indolinone, (d) 3-Z-[1-(4-(dimethylaminomethyl)-anilino)-1-phenyl-methylene]-6-ethoxycarbo nyl-2-indolinone, (e) 3-Z-[1-(4-((2,6-dimethyl-piperidin-1-yl)-methyl)-anilino)-1-phenyl-methyle ne]-6-ethoxycarbonyl-2-indolinone, (f) 3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-acetyl-amino)-anilino)-1-phenyl-met hylene]-6-ethoxycarbonyl-2-indolinone, (g) 3-Z-[1-(4-(N-(3-dimethylamino-propyl)-N-acetyl-amino)-anilino)-1-phenyl-me thylene]-6-ethoxycarbonyl-2-indolinone, (h) 3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-methylsulphonyl-amino)-anilino)-1-p henyl-methylene]-6-ethoxycarbonyl-2-indolinone, (i) 3-Z-[1-(4-(dimethylaminomethyl)-anilino)-1-phenyl-methylene]-6-methoxycarb onyl-2-indolinone, (j) 3-Z-[1-(4-(N-acetyl-N-dimethylaminocarbonylmethyl-amino)-anilino)-1-phenyl -methylene]-6-methoxycarbonyl-2-indolinone, (k) 3-Z-[1-(4-ethylaminomethyl-anilino)-1-phenyl-methylene]-6-methoxycarbonyl- 2-indolinone, (l) 3-Z-[1-(4-(1-methyl-imidazol-2-yl)-anilino)-1-phenyl-methylene]-6-methoxyc arbonyl-2-indolinone, (m) 3-Z-[1-(4-(N-dimethylaminomethylcarbonyl-N-methyl-amino)-anilino)-1-phenyl -methylene]-6-methoxycarbonyl-2-indolinone, (n) 3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-methylsulphonyl-amino)-anilino)-1-p henyl-methylene]-6-methoxycarbonyl-2-indolinone, (o) 3-Z-[1-(4-(N-(3-dimethylamino-propyl)-N-methylsulphonyl-amino)-anilino)-1- phenyl-methylene]-6-methoxycarbonyl-2-indolinone, (p) 3-Z-[1-(4-(N-dimethylaminocarbonylmethyl-N-methylsulphonyl-amino)-anilino) -1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone, (q) 3-Z-[1-(4-(N-((2-dimethylamino-ethyl)-carbonyl)-N-methyl-amino)-anilino)-1 -phenyl-methylene]-6-methoxycarbonyl-2-indolinone, (r) 3-Z-[1-(4-(N-(2-dimethylamino-ethyl)-N-acetyl-amino)-anilino)-1-phenyl-met hylene]-6-methoxycarbonyl-2-indolinone, (s) 3-Z-[1-(4-methylaminomethyl-anilino)-1-phenyl-methylene]-6-methoxycarbonyl -2-indolinone and (t) 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-an ilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone,

or a tautomer or salt thereof.

6. A physiologically acceptable salt of a compound according to claims 1, 2, 3, 4 or 5.

7. A pharmaceutical composition containing a compound according to claims 1, 2, 3 or 4, or a physiologically acceptable salt thereof in accordance with claim 5, together with a pharmaceutically acceptable carrier.

8. 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-an ilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone or a pharmaceutically acceptable salt thereof.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.